Therefore, in addition to [18F]F-DCFBC, [18F]F-PSMA-1007, and [18F]F-DCFPyL, many other 18F-labeled PSMA-targeting agents have been developed (Figure 4) with the aims to further improve the tumor detection accuracy [75,76]. Here, FOLH1 is linked to neoplasm.